Grown Rogue Stock GRUSF Stock analysis & Why GRUSF Stock Goes Up

Former J&J sales rep indicted on charges of defrauding Boston hospital

Dive Brief: A former DePuy Synthes sales representative and team lead was arrested this week for allegedly defrauding a Boston area hospital and lying to

June 28, 2023

Could sickle cell someday be treated not with CRISPR, but with a pill?

Two gene therapies were approved for sickle cell disease last week, but for many researchers the Holy Grail remains something far more modest: A pill.

December 13, 2023

Executive Board member Jens Ravens leaves the Company on April 30, 2024 – Biotech Investments

Epigenomics AG / Key word(s): Personnel Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024 30-Oct-2023 / 15:49 CET/CEST Disclosure

October 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.